Natera (NASDAQ: NTRA) holder lines up $7.9M stock sale after April 10b5-1 trade
Rhea-AI Filing Summary
Daniel Rabinowitz submitted a Form 144 reporting proposed sales of Common Stock and disclosing recent 10b5-1 dispositions. Recent reported dispositions include 8,400 shares on 04/01/2026 for $1,707,814.08, 1,861 shares on 04/27/2026 for $379,811.07, and 330 shares on 05/01/2026 for $68,032.80.
The filing also lists 22,398 Restricted Stock Units (03/27/2024) and 11,202 previously exercised stock options (01/14/2022) as securities to be sold.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 filing documenting proposed resale activity and recent 10b5-1 sales.
The notice lists specific recent dispositions: 8,400 shares for $1,707,814.08, 1,861 shares for $379,811.07, and 330 shares for $68,032.80. These are presented as 10b5-1 sales in the excerpt.
Timing and execution details beyond the dates shown are not included; cash‑flow treatment is not stated in the provided excerpt. Subsequent filings or broker reports would show whether additional resale activity follows.
Key Figures
Key Terms
Form 144 regulatory
10b5-1 sales regulatory
Restricted Stock Units financial
FAQ
What sales did Daniel Rabinowitz report on the Form 144 for NTRA?
Does the Form 144 indicate sales were part of a 10b5-1 plan?
What securities does the filing list as available to sell?
Are proceeds recipients or use of proceeds described in the Form 144?
What exchanges or registration details appear in the excerpt?
AI-generated analysis. How Rhea-AI works. Not financial advice.